Asian Clinical Trials Report issue

For profit Phase 4
Founded: Hyderabad India (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2005
NCT00494533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

treprostinil (remodulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Familial Primary Pulmonary Hypertension (Phase 4)

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1